Condition
Neoadjuvant Chemotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Neoadjuvant Chemotherapy clinical trials that are recruiting, at sites in 6 countries (most in China (6), United States (2), Italy (2)). By phase: Phase 3 (4), Early Phase 1 (1), Phase 2/3 (1). The most active sponsors are Second Affiliated Hospital, Zhejiang University, School of Medicine (2), European Institute of Oncology (2). There are also 10 NIH-funded research projects on Neoadjuvant Chemotherapy, with $5.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 10NIH research projects
- 6Countries
Newest Neoadjuvant Chemotherapy clinical trials
All recruiting trials (13)
-
Tracking frailty and thinking before and after pre-surgery chemotherapy for advanced ovarian and endometrial cancer
This study will see if an automated frailty score and brief thinking tests change after 3–4 cycles of neoadjuvant (pre-surgery) chemotherapy in people over 55 with advanced ovarian or endometrial cancer.
-
Seismocardiography to gauge fitness and predict outcomes before esophageal cancer surgery
A noninvasive seismocardiography device is tested to see if it can quickly estimate a patient’s fitness and help predict surgical outcomes for adults with esophageal cancer who are planning curative treatment.
-
Sentinel lymph node biopsy after neoadjuvant chemotherapy for inflammatory breast cancer
This trial will test whether sentinel lymph node biopsy after preoperative chemotherapy is feasible and safe for people with inflammatory breast cancer who initially had extensive lymph node involvement.
-
AI-guided ultrasound and MRI staging to guide bladder cancer treatment
This project will test whether a deep-learning system using ultrasound, MRI, and pathology can more accurately stage bladder cancer and predict who will benefit from additional chemotherapy for patients with suspected bladder tumors.
-
Megestrol acetate to prevent weight loss during preoperative chemotherapy for locally advanced colorectal cancer
This trial tests whether taking megestrol acetate during mFOLFOX6 neoadjuvant chemotherapy can prevent weight loss and improve appetite in adults with locally advanced colorectal cancer.
-
Comparing standard and prolonged chemotherapy before surgery for pancreatic cancer
This study is testing whether giving longer chemotherapy before surgery can help people with tough-to-treat pancreatic cancer live longer and have better outcomes.
-
Non-surgical treatment for breast cancer after chemotherapy
This study tests if using radiotherapy alone is a safe and effective option for breast cancer patients who have responded well to chemotherapy, instead of undergoing surgery.
-
Using advanced mammography techniques to assess breast cancer treatment response
This study is testing two new mammography techniques to see if they can better predict how well chemotherapy is working for people with locally advanced breast cancer.
-
Using organoids to test chemotherapy sensitivity in breast cancer patients
This study is testing if lab-grown mini tumors from breast cancer patients can help predict how well they will respond to chemotherapy before treatment starts.
-
Comparing chemotherapy before and after surgery for pancreatic cancer
This study is testing whether giving chemotherapy before surgery can help people with resectable pancreatic cancer do better and live longer, especially in Asian patients.
-
Neoadjuvant chemotherapy followed by chemoradiation for advanced cervical cancer
This study is testing if giving a special chemotherapy before standard radiation treatment can help people with advanced cervical cancer live longer and feel better.
-
Combining Camrelizumab with chemotherapy for left-sided obstructive colorectal cancer
This study tests if combining a new immunotherapy drug with chemotherapy can help people with left-sided obstructive colorectal cancer live longer and have better surgery outcomes after getting a stent.
-
Evaluating a new chemotherapy regimen for HER2-negative breast cancer before surgery
This study is testing a new type of chemotherapy to see if it works better than standard treatment for women with HER2-negative breast cancer before they have surgery.
NIH-funded research (10)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Magnetic resonance fingerprinting to gauge chemotherapy response in breast cancer
A patient-facing look at using a special MRI method (MRF) to see early whether breast cancer is responding to preliminary chemotherapy.
-
MRI-guided chemotherapy for borderline-resectable pancreatic cancer
This project uses special MRI scans to help pick the best pre-surgery chemotherapy for people whose pancreatic tumor is touching nearby vessels but might be removable after treatment.
-
3D wearable NIR imaging to predict breast cancer response during treatment
A noninvasive, portable 3D wearable optical test (NIRS tomography) will be used to spot early signs of how breast cancer is responding to chemotherapy, helping guide treatment for patients.
-
MRI fingerprinting to spot early breast tumor response to chemotherapy given before surgery
This project uses a new MRI method to find early changes in breast tumors during chemotherapy given before surgery so doctors can change treatment sooner if needed.
-
Improving how we track breast cancer chemotherapy with 3D imaging
This project aims to develop a new 3D ultrasound method to see how well chemotherapy is working for breast cancer patients before surgery.
-
New Wearable Imaging to See How Breast Cancer Responds to Chemotherapy
This project is developing a new wearable imaging device to help doctors see very early if breast cancer treatment is working for patients receiving chemotherapy before surgery.
-
Using 3D wearable technology to predict breast cancer treatment outcomes
This study is testing a new, easy-to-use imaging method that helps doctors see how well chemotherapy is working for breast cancer patients, so they can better understand how much cancer is left after treatment and improve chances for a healthier future.
-
How pre-surgery chemotherapy affects breast cancer spread
This study is looking at how chemotherapy for breast cancer might sometimes help cancer cells spread to other parts of the body, and it aims to understand the role of certain immune cells in this process, which could lead to better treatment options for patients like you.
-
Using Magnetic Resonance Fingerprinting to Evaluate Breast Cancer Treatment Response
This study is testing a new imaging method to help doctors see how well breast cancer patients are responding to their chemotherapy before surgery, so they can make better treatment decisions and improve results.
-
Examining lymph node biopsy techniques after chemotherapy in advanced breast cancer patients
This study is looking at whether a less invasive procedure called sentinel lymph node biopsy can help women with locally advanced breast cancer who have received chemotherapy, making it easier to check for cancer spread in the armpit without needing more complicated surgeries.
Related topics
Quick answers
How many Neoadjuvant Chemotherapy clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (6 trials), United States (2 trials), Italy (2 trials), United Kingdom (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4, Early Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.